Back to DRIEHAUS CAPITAL MANAGEMENT LLC DRIEHAUS CAPITAL MANAGEMENT LLC

ADPTADPT
10 quarters

Position history for DRIEHAUS CAPITAL MANAGEMENT LLCDRIEHAUS CAPITAL MANAGEMENT LLC's holdings in ADAPTIVE BIOTECHNOLOGIES COR

Yes. Driehaus Capital Management holds 2,527,703 shares of ADPT (Adaptive Biotechnologies), worth $54.2M, as of its Q2 2026 13F filing. It increased the position by 777,102 shares (+44.4%) from Q1 2026. Driehaus Capital Management has held ADPT since Q3 2024, across 8 quarterly 13F filings. ADPT is 0.3% of Driehaus Capital Management's reported 13F portfolio.

Current Value

$54.2M

Current Shares

2.5M

Total Value Change

+$52M

Total Shares Change

+2.5M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
2.5M
+44.4%
$54.2M0.3%$21.45
47
2026-Q1
Decreased
1.8M
-36.6%
$24.3M0.2%$16.08
0
2025-Q4
Decreased
2.8M
-8.6%
$44.8M0.3%$16.42
0
2025-Q3
Increased
3M
+24.6%
$45.2M0.3%$13.46
43
2025-Q2
Increased
2.4M
+12.6%
$28.2M0.2%$11.79
39
2025-Q1
Increased
2.2M
+154.4%
$16M0.2%$7.67
54
2024-Q4
Increased
846,171
+94.4%
$5.1M0.0%$6.11
43
2024-Q3
New
435,294
-
$2.2M0.0%$5.00
36
2019-Q3
Exited
0
-100.0%
$00.0%$30.31
0
2019-Q2
New
46,490
-
$2.2M0.1%$48.30
36

Other major holders of ADPT: VIKING GLOBAL INVESTORS LP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used